Literature DB >> 25906441

Does functional health status predict health-related quality of life in children after Fontan operation?

Karolijn Dulfer1, Sjoerd S M Bossers2, Elisabeth M W J Utens1, Nienke Duppen2, Irene M Kuipers3, Livia Kapusta4, Gabrielle van Iperen5, Michiel Schokking4, Arend D J ten Harkel6, Tim Takken7, Willem A Helbing2.   

Abstract

PURPOSE: It is important to identify those children with a Fontan circulation who are at risk for impaired health-related quality of life. We aimed to determine the predictive value of functional health status - medical history and present medical status - on both physical and psychosocial domains of health-related quality of life, as reported by patients themselves and their parents.
METHODS: We carried out a prospective cross-sectional multi-centre study in Fontan patients aged between 8 and 15, who had undergone staged completion of total cavopulmonary connection according to a current technique before the age of 7 years. Functional health status was assessed as medical history - that is, age at Fontan, type of Fontan, ventricular dominance, and number of cardiac surgical procedures - and present medical status - assessed with magnetic resonance imaging, exercise testing, and rhythm assessment. Health-related quality of life was assessed with The TNO/AZL Child Questionnaire Child Form and Parent Form.
RESULTS: In multivariate prediction models, several medical history variables, such as more operations post-Fontan completion, lower age at Fontan completion, and dominant right ventricle, and present medical status variables, such as smaller end-diastolic volume, a higher score for ventilatory efficiency, and the presence of sinus node dysfunction, predicted worse outcomes on several parent-reported and self-reported physical as well as psychosocial health-related quality of life domains.
CONCLUSIONS: Medical history and worse present medical status not only predicted worse physical parent-reported and self-reported health-related quality of life but also worse psychosocial health-related quality of life and subjective cognitive functioning. These findings will help in identifying patients who are at risk for developing impaired health-related quality of life.

Entities:  

Keywords:  Fontan circulation; congenital heart disease; quality of life

Mesh:

Year:  2015        PMID: 25906441     DOI: 10.1017/S1047951115000426

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  5 in total

1.  Hypoplastic Left Heart Syndrome is not Associated with Worse Clinical or Neurodevelopmental Outcomes Than Other Cardiac Pathologies After the Norwood-Sano Operation.

Authors:  Billie-Jean Martin; I De Villiers Jonker; Ari R Joffe; Gwen Y Bond; Bryan V Acton; David B Ross; Charlene M T Robertson; Ivan M Rebeyka; Joseph Atallah
Journal:  Pediatr Cardiol       Date:  2017-03-24       Impact factor: 1.655

2.  Is Neurodevelopment Related to Exercise Capacity in Single Ventricle Patients Who Have Undergone Fontan Palliation?

Authors:  Sean J Cooney; Kristen Campbell; Kelly Wolfe; Michael V DiMaria; Christopher M Rausch
Journal:  Pediatr Cardiol       Date:  2020-11-15       Impact factor: 1.655

3.  Fontan Geometry and Hemodynamics Are Associated With Quality of Life in Adolescents and Young Adults.

Authors:  Laura Mercer-Rosa; Mark A Fogel; Zhenglun Alan Wei; Phillip M Trusty; Michael Tree; Elaine Tang; Maria Restrepo; Kevin K Whitehead; Amy Cassedy; Stephen M Paridon; Ajit Yoganathan; Bradley S Marino
Journal:  Ann Thorac Surg       Date:  2022-02-01       Impact factor: 5.102

4.  Health-Related Quality of Life in Children, Adolescents, and Adults With a Fontan Circulation: A Meta-Analysis.

Authors:  Kate H Marshall; Yves D'Udekem; Gary F Sholler; Alexander R Opotowsky; Daniel S J Costa; Louise Sharpe; David S Celermajer; David S Winlaw; Jane W Newburger; Nadine A Kasparian
Journal:  J Am Heart Assoc       Date:  2020-03-16       Impact factor: 5.501

Review 5.  State of the art of the Fontan strategy for treatment of univentricular heart disease.

Authors:  Jelle P G van der Ven; Eva van den Bosch; Ad J C C Bogers; Willem A Helbing
Journal:  F1000Res       Date:  2018-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.